Global Asthma and COPD Devices Market 2021
- Market Report
- ID: HL20907G
- Delivery Time: 1 Business Day
- Tag: Asthma and COPD Devices
Description
Asthma and COPD, including emphysema and chronic bronchitis are inflammatory diseases that cause airflow blockage and breathing-related problems. The global asthma and COPD devices market in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period, according to data and analytics company StrategyHelix. North America held the highest share in the global asthma and copd devices market, while Asia Pacific is expected to grow at the highest CAGR during the forecast period. Increase in incidence and prevalence of asthma and COPD and growing geriatric population are driving market growth.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value and volume for asthma and COPD devices. The global asthma and COPD devices market is segmented on the basis of product, application, end user, and region. By product, it is categorized into diagnostic devices, and monitoring devices. The diagnostic devices segment held the largest market share in 2020. However, the monitoring devices segment is expected to witness the highest CAGR during the forecast period. By application, the asthma and COPD devices market is divided into asthma, and COPD. The asthma segment accounted for the largest market share in 2020. Based on end user, the asthma and copd devices market is divided into hospitals and clinics, and homecare.
The report has profiled some of the key players of the market such as Becton Dickinson and Company (BD), Draegerwerk AG & Company KGAA, Getinge AB, Invacare Corporation, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, NIHON KOHDEN CORPORATION, Smiths Medical Inc., VYAIRE MEDICAL INC..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the asthma and COPD devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Product: diagnostic devices, and monitoring devices
Application: asthma, and COPD
End user: hospitals and clinics, and homecare
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global asthma and COPD devices market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global asthma and COPD devices market looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Asthma and COPD Devices Market by Product
4.1 Diagnostic Devices
4.2 Monitoring Devices
5. Asthma and COPD Devices Market by Application
5.1 Asthma
5.2 Copd
6. Asthma and COPD Devices Market by End User
6.1 Hospitals And Clinics
6.2 Homecare
7. Asthma and COPD Devices Market by Region
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. Company Profiles
8.1 Becton, Dickinson and Company (BD)
8.2 Draegerwerk AG & Company KGAA
8.3 Getinge AB
8.4 Invacare Corporation
8.5 Koninklijke Philips N.V.
8.6 Masimo Corporation
8.7 Medtronic plc
8.8 NIHON KOHDEN CORPORATION
8.9 Smiths Medical, Inc.
8.10 VYAIRE MEDICAL INC.
9. Appendix
9.1 About StrategyHelix
9.2 Disclaimer
USD 2,250